Institute For Protein Innovation Inc is a 501(c)(3) organization based in Boston, Massachusetts, registered in 2017, with $7,481,529 in FY2024 revenue. CharityIndex grades it C, and it directs about 74% of spending to programs.
Revenue (FY2024)
$7.5M
▲ 61.0% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$17.5M
Net assets
$199.1M
Employees
63
Rated on 4 of 4 criteria.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Institute For Protein Innovation Inc: 74% to programs · $0 to raise $100 earns a B on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Institute For Protein Innovation Inc: 136 mo reserves · -134% margin earns a F on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Institute For Protein Innovation Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Institute For Protein Innovation Inc: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To advance protein science to accelerate research and improve human health.
Revenue declined from $10.1M (FY2016) to $7.5M (FY2024) across 9 reported years.
Financial snapshot
Operating margin
-134.4%
Spent more than it raised in the latest fiscal year.
Total assets
$204.5M
Total liabilities
$5.4M
Net assets
$199.1M
Salaries & benefits
$8.6M
49% of expenses
Board members
11
10 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $7,481,529▲61.0% | $17,537,203▲20.1% | $199,123,040▲0.8% | $204,496,998▲1.3% | 990 |
| 2023 | $4,647,929▲15.5% | $14,602,368▲10.6% | $197,613,611▲3.4% | $201,899,474▲2.6% | 990 |
| 2022 | $4,022,792▼22.3% | $13,197,650▲20.1% | $191,203,690▲0.7% | $196,826,153▲3.0% | 990 |
| 2021 | $5,178,433▼97.4% | $10,986,031▲18.1% | $189,930,932▼12.9% | $191,011,980▼12.8% | 990 |
| 2020 | $200,786,087▲714% | $9,301,960▲22.8% | $217,973,255▲753% | $219,080,402▲725% | 990 |
| 2019 | $24,674,930▲1522% | $7,577,015▲6.8% | $25,549,481▲202% | $26,558,611▲188% | 990 |
| 2018 | $1,521,195▼82.6% | $7,094,240▲84.0% | $8,451,566▼39.4% | $9,234,111▼39.9% | 990 |
| 2017 | $8,755,283▼13.3% | $3,855,437▲624% | $13,946,388▲45.8% | $15,361,567▲57.5% | 990 |
| 2016 | $10,096,202 | $532,195 | $9,564,007 | $9,755,889 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Kenneth Fasman — $698,168 (3.98% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Kenneth Fasman | President & Ceo/ex-officio | 40 | $698,168 |
| Rob Meijers | Senior Director Antibody Platform | 40 | $278,006 |
| Bettina Stevens | Cfo (until 10/24) | 40 | $248,242 |
| Trisha Gura | Dir. of Communications | 40 | $239,660 |
| Andre Teixeira | Sr. Dir. of Antibody Platform | 40 | $238,270 |
| Deborah Moshinsky | Director Antibody Characterization | 40 | $237,606 |
| Curtis Walton | Director of Laboratory Automation | 40 | $233,334 |
| Dr Amir Nashat | Director | 1 | — |
| Dr Auro Nair | Director | 1 | — |
| Dr Jeffrey Flier | Director (until 12/24) | 1 | — |
| Dr Maykin Ho | Director | 1 | — |
| Dr Rusty Williams | Director | 1 | — |
| Dr Stephen Blacklow | Director | 1 | — |
| Dr Steven C Almo | Director | 1 | — |
| Dr Timothy A Springer | Co-founder/director | 1 | — |
| Israel Rozen | Director | 1 | — |
| Michael O'hara | Treasurer | 1 | — |
| Samantha Singer | Chair | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Nelson Mullins Riley & Scarborough LLP | Legal Services | $204,918 |
| Danforth Advisors LLC | Accounting Services | $154,750 |
5 grants to Institute For Protein Innovation Inc totaling $1.5M, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Silicon Valley Community Foundation | Health | 2024 | $500,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2022 | $10,000 |
| President and Fellows of Harvard College | Sponsored research sub-award | 2021 | $9,077 |
| President and Fellows of Harvard College | Sponsored research sub-award | 2020 | $81,387 |
| International Aids Vaccine Initiative Inc | Research & development | 2018 | $894,057 |
Explore more
Data for Institute For Protein Innovation Inc (EIN 81-3250208) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.